Overview
An AFB smear detects organisms with mycolic-acid–rich cell walls that retain primary dye after acid-alcohol decolorization.
Clinical Importance
Rapid screening for mycobacteria in respiratory and other specimens
Support infection-control and treatment urgency decisions pending culture/NAAT
Specimen Requirements
- Specimen: site-appropriate clinical material collected aseptically per institutional protocol
- Container: sterile container or transport medium validated for the ordered test
- Handling: transport promptly at the temperature specified for the method; avoid refrigeration when anaerobes or certain pathogens are suspected unless SOP directs otherwise
- Labeling: two patient identifiers, collection time/date, and anatomic site
- Stability: organism viability and antigen/nucleic acid stability are method-specific; do not exceed local time limits
- Respiratory specimens are most common; follow local concentration/decontamination protocols when indicated
Analytical Method
Ziehl-Neelsen or Kinyoun carbolfuchsin methods, or auramine (± rhodamine) fluorochrome staining, are used. Acid-fast organisms resist decolorization and appear red (bright-field) or fluorescent (fluorochrome) against a counterstained background.
Instruments Used
Automated analyzers
- Fluorescence microscopes for auramine-based screening
- Digital imaging systems in selected high-volume mycobacteriology laboratories
Manual methods
- Manual Ziehl-Neelsen / Kinyoun staining with bright-field oil immersion
- Manual fluorochrome screening with confirmatory review per SOP
Reference Values
Microbiology results are interpreted against organism identification, specimen quality, clinical context, and current CLSI and/or EUCAST interpretive criteria (including CLSI M100 for susceptibility where adopted). Reporting conventions and critical-notification lists are institution-defined; verify against the performing laboratory SOP and current guideline editions.
No numeric clinical reference interval. Results are typically reported as negative or graded positive (e.g., rare to numerous AFB) per laboratory convention / WHO-style grading schemes where used.
Smear sensitivity is lower than culture or NAAT; a negative smear does not exclude mycobacterial infection.
Interpretation
Critical and significant-risk microbiology findings (e.g., positive blood culture, CSF pathogen) follow institutional urgent-notification pathways. Confirm the local call list. Textbook examples are not universal thresholds.
Critical values
- First-positive AFB smear from a new patient often requires urgent notification and infection-control pathways
Common Causes of Increased Results
- AFB seen; correlate with NAAT/culture and clinical/radiologic context; quantify per local grading
Common Causes of Decreased Results
- Negative smear; still pursue culture/NAAT when clinical suspicion remains
Clinical Significance
- Suspected pulmonary or extrapulmonary tuberculosis workup
- Monitoring smear conversion in selected treatment protocols (clinical pathway–dependent)
Factors Affecting Results
Pre-analytical
- Inadequate sputum quality or volume
- Failure to concentrate specimens when protocol requires it
Analytical
- Insufficient fields examined
- Fluorochrome quenching or poor microscope setup
- Nocardia and partially acid-fast organisms may confuse interpretation; use modified methods when indicated
Post-analytical
- Reporting without correlating NAAT/culture orders
Advantages and Limitations
Advantages
- Rapid turnaround relative to mycobacterial culture
- Supports urgency triage
Limitations
- Limited sensitivity vs culture/NAAT
- Does not identify Mycobacterium tuberculosis complex vs NTM on morphology alone
Clinical Pearls
A negative AFB smear is not a stop order; culture and molecular testing carry the diagnostic weight when suspicion is high.
References
Authoritative textbooks, guidelines, and reviews supporting this laboratory test reference. Verify reference intervals, critical limits, and method details against institutional protocols and current guideline editions.
Textbooks
- Carroll KC, Pfaller MA, Landry ML, et al., eds. Manual of Clinical Microbiology. ASM Press (verify current edition).
- Forbes BA, Sahm DF, Weissfeld AS. Bailey & Scott's Diagnostic Microbiology. 15th ed. Elsevier; 2020.
- Mahon CR, Lehman DC, Manuselis G. Textbook of Diagnostic Microbiology. 6th ed. Elsevier; 2018.
- Carroll KC, Hobden JA, Miller S, et al. Jawetz, Melnick, & Adelberg's Medical Microbiology. 28th ed. McGraw-Hill; 2019.
- Murray PR, Rosenthal KS, Pfaller MA. Medical Microbiology. 9th ed. Elsevier; 2021.
CLSI and Professional Guidelines
- Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing. CLSI document M100 (verify current edition and institutional adoption).
- Centers for Disease Control and Prevention / NIH. Biosafety in Microbiological and Biomedical Laboratories (BMBL). Current edition (verify institutional adoption).
WHO Publications
- World Health Organization. Laboratory and diagnostic guidance relevant to clinical microbiology practice (verify current WHO publication for the method).
Frequently Asked Questions
Common questions about using this Acid-Fast Bacilli (AFB) Smear laboratory test Medical Laboratory Library reference in Medical Laboratory Science education.
What is the Acid-Fast Bacilli (AFB) Smear laboratory test reference used for?
This Medical Laboratory Library page summarizes the clinical importance of Acid-Fast Bacilli (AFB) Smear. Review the Clinical Importance section for why the test is ordered in laboratory medicine practice.
Where can I find Acid-Fast Bacilli (AFB) Smear specimen requirements?
See the Specimen Requirements section on this page for specimen information related to Acid-Fast Bacilli (AFB) Smear. Confirm collection details against your laboratory protocol.
Where are Acid-Fast Bacilli (AFB) Smear reference values listed?
See the Reference Values section on this Laboratory Library page. Reference ranges can vary by method and population, so verify intervals with your laboratory.
How do I interpret Acid-Fast Bacilli (AFB) Smear results?
Use the Interpretation section for laboratory interpretation framing, including increased and decreased result patterns when provided. Do not treat educational text as a patient-specific diagnosis.
What analytical method is used for Acid-Fast Bacilli (AFB) Smear?
See the Analytical Method section for principle and method notes. Method details may differ by instrument and institutional SOP.
Are related laboratory tests linked from Acid-Fast Bacilli (AFB) Smear?
Yes. The Related Laboratory Tests section lists connected references for continued lookup in the Medical Laboratory Library.
How can I continue learning after reading Acid-Fast Bacilli (AFB) Smear?
Use Continue learning links on this page for related Academy lessons, medical laboratory quizzes, or laboratory case studies when available for this Medical Microbiology topic.
What are the clinical pearls for Acid-Fast Bacilli (AFB) Smear?
See the Clinical Pearls section for concise laboratory practice notes associated with Acid-Fast Bacilli (AFB) Smear. Apply pearls alongside institutional protocols.
Reading progress
Awards XP once after you have meaningfully reviewed this article.